Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Rose Today

TheMotleyFool

0 0

Shares of Moderna (NASDAQ: MRNA) climbed 3.6% on Thursday after the drugmaker announced the completion of enrollment for its COVID-19 vaccine study.

Moderna has enrolled 30,000 people for the phase 3 trial for its coronavirus vaccine candidate, mRNA-1273. The biotech noted that 42% of the participants are from groups deemed to be at high risk of severe COVID-19 disease, including more than 7,000 Americans over the age of 65 and 5,000 people who are younger but have chronic diseases, such as severe obesity and diabetes.

Moderna's stock rallied on Thursday as investors applauded its vaccine testing progress. Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Share